Humoral immune deficiency in multiple myeloma patients due to compromised B-cell function
- 1 November 1986
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 6 (6) , 491-501
- https://doi.org/10.1007/bf00915255
Abstract
Patients with multiple myeloma are generally immunodeficient, with pronounced depression in primary antibody responses. We have attempted to delineate the reasons for the humoral immunodeficiency by analyzing the specificity repertoire of the surface immunoglobulin (Ig)-positive B cells in patients with multiple myeloma or monoclonal gammopathy of undetermined significance (MGUS), in comparison with normal donors. B lymphocytes from 26 patients with multiple myeloma, 12 patients with MGUS, and 8 normal donors were transformed with Epstein-Barr virus (EBV) and cultured at limiting dilution for clonal analysis. The Ig secreted by each clone was analyzed for class and anti-tetanus toxoid (TT) specificity to determine the frequencies of IgM, IgG, anti-TT IgM, and anti-TT IgG antibody-secreting clones. Our objective was to establish whether the inability to mount humoral responses to common environmental pathogens was due to a lack of specific B cells or to inhibition of B-cell function. Our results indicate that the quantitative B-cell deficiency in patients was due to a nonrandom loss of selected sets of B cells. Although most patients had a reduced aggregate number of B cells, the number of TT-specific B cells was normal. There was, on average, a threefold increase in the proportion of the B-cell specificity repertoire devoted to recognition of TT. Forty-four percent of the patients with MGUS were also affected. In addition, the TT-specific B cells in multiple myeloma patients were severely compromised in their ability to secrete antibody or to differentiate to antibody-secreting cellsin vivo. This arrest in differentiation appears to be extrinsic to the B cells, as they were fully able to secrete anti-TT antibody after transformation and culturein vitro. We postulate the existence of an autoimmune inhibitory network mediating the arrest in B-cell differentiation and the humoral immune deficiency.This publication has 34 references indexed in Scilit:
- Antibody Response to Pneumococcal Vaccination in Patients with MyelomatosisScandinavian Journal of Haematology, 2009
- Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. Lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levels.Journal of Clinical Investigation, 1985
- Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients.Journal of Clinical Investigation, 1984
- Frequencies of the separate human B cell subsets activatable to Ig secretion by Epstein-Barr virus and pokeweed mitogen.The Journal of Experimental Medicine, 1983
- Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells.The Journal of Experimental Medicine, 1983
- Characteristics of Epstein-Barr virus activation of human B lymphocytes.The Journal of Experimental Medicine, 1981
- Suppression of polyclonal immunoglobulins in multiple myeloma: Relationship to the staging and other manifestations at diagnosisClinical Immunology and Immunopathology, 1980
- Studies on the Pathogenesis of an Immune Defect in Multiple MyelomaJournal of Clinical Investigation, 1977
- Immunological Deficiency Disorders Associated with Chronic Lymphocytic Leukemia and Multiple Myeloma*Journal of Clinical Investigation, 1964
- Production of Antibodies against Viruses in Leukaemia and Related DiseasesBritish Journal of Haematology, 1964